NSEUpdates25 Jun 2026 · 25 Jun 2026, 10:08 am
Updates
Concord Biotech Limited · CONCORDBIO
✦ AI Summary▲ PositiveRegulatory
Concord Biotech Limited has completed the inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at its Unit-II formulation facility.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Limited has informed the Exchange regarding 'Completion of Inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit-II formulation facility'.